Setting prices for generic medications: A survey of patients' perceptions

American Journal of Pharmacy Benefits

Volumn 2, Issue 1, 2010, Pages 33-38

  Choudhry, Niteesh K ^a,b   Cox, Emily R ^c   Fischer, Michael A ^a,b   Mehta, Jyotsna ^a,b   Shrank, William H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Express Scripts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; GENERIC DRUG; HYPOCHOLESTEROLEMIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG COST; DRUG MARKETING; ETHNIC DIFFERENCE; FEMALE; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; MALE; PERCEPTION;

EID: 77953443764     PISSN: 19454481     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kohl H, Shrank WH. Increasing generic drug use in Medicare Part D: the role of government. J Am Geriatr Soc. 2007;55(7):1106-1109.
2. Kesselheim AS, Choudhry NK. The international pharmaceutical market as a source of low-cost prescription drugs for U.S. patients. Ann Intern Med. 2008;148(8):614-619.
3. Kaiser Family Foundation. Prescription Drug Trends. May 2007. http://www.kff.org/rxdrugs/upload/3057-06.pdf. Accessed December 5, 2007.
4. Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med. 2005;142(11):891-897.
5. Fischer MA, Avorn J. Economic implications of evidence-based prescribing for hypertension: can better care cost less? JAMA. 2004;291(15):1850-1856.
6. Shrank WH, Hoang T, Ettner SL, et al. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med. 2006;166(3):332-337.
7. Kaiser Family Foundation. An In-Depth Examination of Formularies and Other Features of Medicare Drug Plans. April 2006. http://www.kff.org/medicare/ 7489.cfm. Accessed October 21, 2009.
8. Kaiser Family Foundation and Health Research and Educational Trust. Employer Health Benefits 2007 Annual Survey. http://www.kff.org/insurance/7672/ index.cfm. Accessed January 31, 2008.
9. Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG. The effect of incentive-based formularies on prescription-drug utilization and spending. N Engl J Med. 2003;349(23):2224-2232.
10. Rector TS, Finch MD, Danzon PM, Pauly MV, Manda BS. Effect of tiered prescription copayments on the use of preferred brand medications. Med Care. 2003;41(3):398-406.
11. Shrank WH, Stedman M, Ettner SL, et al. Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. J Gen Intern Med. 2007;22(9):1298-1304.
12. O'Malley AJ, Frank RG, Kaddis A, Rothenberg BM, McNeil BJ. Impact of alternative interventions on changes in generic dispensing rates. Health Serv Res. 2006;41(5):1876-1894.
13. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991;10(4):585-598.
14. Mager DE, Cox ER. Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate. Am J Manag Care. 2007;13(6 pt 2):347-352.
15. Claxton G, Gabel J, DiJulio B, et al. Health benefits in 2007: premium increases fall to an eight-year low, while offer rates and enrollment remain stable. Health Aff (Millwood). 2007;26(5):1407-1416.
16. Mahoney JJ. Reducing patient drug acquisition costs can lower diabetes health claims. Am J Manag Care. 2005;11(5 suppl):S170-S176.
17. Chernew ME, Shah MR, Wegh A, et al. Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff (Millwood). 2008;27(1):103-112.
18. Boulware LE, Cooper LA, Ratner LE, LaVeist TA, Powe NR. Race and trust in the health care system. Public Health Rep. 2003;118(4):358-365.
19. Soumerai SB, Pierre-Jacques M, Zhang F, et al. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the Medicare drug benefit. Arch Intern Med. 2006;166(17):1829-1835.
20. Gellad WF, Haas JS, Safran DG. Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med. 2007;22(11):1572-1578.